Journals Library

Title page


Authors are responsible for writing a title that is accurate, clear and short – no more than 20 words. The title is important, in part, for ensuring that relevant reviewers are found and for enabling readers to find your published report. It should say what the report is about and include, within the word limit, the main methods. If there is an RCT, that should always be mentioned. Please try to avoid using terms like “the effectiveness of” or “researching into”.

The format of the title should be: Intervention + patient group: main study method + acronym (if widely used).

If the report includes a randomised control trial, please include 'RCT' in the title after the colon.

For example: Anti-psychotic drug reduction for adults with learning disabilities: the ANDREA-LD pilot RCT

Characteristics and needs of long-stay patients in high and medium secure settings: a mixed methods study

For Programme Grants for Applied Research, use the format: “Subject: the XXX research programme”.  For example: Reducing relapse and suicide in bipolar disorder: the PARADES research programme including 3 RCTs

Your title should be submitted with your final report. It will be reviewed during the editorial process for consistency and clarity. The final decision rests with NETSCC. 


NETSCC will write a headline, following the guidance set out here, and then review it in discussion with the authors and the editors.  It is intended to state the main findings or primary outcome of the report accurately and concisely, in a single sentence and no more than 30 words, and in a way that reflects the language in the Abstract and Scientific Summary as much as possible.  The final decision rests with NETSCC.  Programme Grant headlines should start with ‘This research programme…’

For example:

Intravenous antibiotics were not more likely than oral antibiotics to achieve eradication of Pseudomonas aeruginosa infection at three months and patients remaining infection free at 15 months. 

This study found there was weak evidence of the effectiveness of school-based, disorder-specific interventions for the prevention of anxiety, depression, and conduct disorder in children and young people. 

PGfAR - This research programme developed a feasible and acceptable intervention to support adherence to inhaled medication, but this did not reduce pulmonary exacerbation rates after 12 months. 


Please provide a list of keywords for your report.  HTA and EME report authors are expected to use MeSH on Demand to generate appropriate keywords from their scientific summary.

Author List

Your title page must include details of authors’ names and their institutional affiliation at the time they worked on the report (including department, full address and country).   If you would like to include a group or collaboration within your author list, please see the below information for details.  Please also provide the corresponding author's contact details (including email, telephone number and address).

Author guidelines for presentation of long author lists

Lists that have many names

Text presentation

All authors should be listed on the title page, regardless of how many names there are. If there are too many names to fit on one page, the list will carry over to the following page. For the press cover, the names will continue to the first inside page.

Lists of members of groups named in the author list as authors

Groups that are listed as full authors in the author list, i.e. where the group name is included directly in the author list and does not follow ‘on behalf of’, will have their members listed as non-author collaborators on PubMed. See  for more information.

Text presentation

The group name should appear directly in the author list on the title page (i.e. not following ‘on behalf of’). 

The names of individual group members should appear in Appendix 1.  

If there is more than one group listed as an author, each group should be listed in its own appendix.

The appendix should be titled with the name of the group, for example:

Appendix 1 Members of the Good Research Group

In the appendix, the authors should be formatted as follows, one per line:

Jane Smith, Department of Investigations, Research University, Studyton.

Roles, affiliations and ORCID IDs can be included, but they will not be displayed on PubMed. If they are present, they should appear after the name, on the same line. If more than one author has the same affiliation, the affiliation should be repeated.

Lists of members of groups mentioned in the author list as ‘on behalf of’

If a group is listed at the end of the author list with the prefix ‘on behalf of’, this implies that the authors, who are working on behalf of the group, have published the report, and the group as a whole is not a direct author of the report. 

Group member names will not appear in PubMed. Naming the members of the group is therefore for acknowledgement only. 

Text presentation

The group name should appear at the end of the author list on the title page, prefixed by the text ‘on behalf of’. 

The names of the group members do not have to be shown, but if they are given, they should appear as part of the Acknowledgements section, under a sub-heading containing the name of the group; for example:

Members of the Good Research Group

Disclosure of Interest 

A disclosure of interest declaration must also appear below the authors’ names. For example:

"Disclosure of interest: XXXX has received funding from the pharmaceutical industry to attend an influenza-related conference"


"Disclosure of interest: None declared"

Link open in a new windowThe NIHR Journals Library adopts the International Committee of Medical Journal Editors (ICMJE) approach to disclosure of interest, as discussed in detail here:

The NIHR Journals Library requires that all authors must complete the ICMJE Disclosure of  Interest form. Authors are asked to note that this form asks for all potential disclosures and if in doubt, authors are asked to be inclusive in their declaration. In particular authors are reminded that ICMJE include the following as potential disclosures of interest:

(1) Relevant financial activities outside the submitted work.

(2) Intellectual Property.

(3) Relationships not covered above.

(4) This includes details of other NIHR funding such as NIHR professorships and CLAHRC funding.

For further information please see the ICMJE Disclosure of Interest form.